Chewy Earnings Reports

Chewy's Q4 2024 earnings showed net sales of $3.25 billion, up 14.9% year-over-year. The company reported a net income of $22.8 million and adjusted net income of $120 million. Gross margin expanded to 28.5%, while free cash flow more than doubled to $156.6 million.

Chewy reported an 8.2% increase in net sales, reaching $2.74 billion. The gross margin remained strong at 28.5%. The company reported a net loss of $35.8 million, but adjusted EBITDA increased to $82.1 million.

Chewy reported record net sales of $1.78 billion, a 45% increase year-over-year. Gross margin expanded to 25.5%, and adjusted EBITDA improved significantly. The company's focus on execution and inventiveness drove positive results, with strategic initiatives in proprietary brands and healthcare offerings contributing to the momentum.

Chewy reported net sales of $1.70 billion, a 47% year-over-year increase. The company's gross margin expanded to 25.5%, and it achieved positive adjusted EBITDA for the second consecutive quarter. The net loss was $32.8 million, which included share-based compensation expenses.

Chewy reported a strong start to 2020 with net sales increasing 46% year-over-year and gross margins expanding 50 basis points. The company achieved its first-ever quarter of positive adjusted EBITDA.

Chewy reported strong fourth-quarter results with net sales of $1.35 billion, representing a 35% year-over-year growth. The company's gross margin expanded by 320 basis points. Net loss was $60.9 million, and adjusted EBITDA loss improved significantly.